Bell Investment Advisors’s Haemonetics HAE Stock Holding History

Bell Investment Advisors’s Portfolio HAE Stock Details HAE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$2.17K	Hold	29	–	–	﹤0.01%	1309
2026 Q1	$1.64K	Hold	29	–	–	﹤0.01%	1390
2025 Q4	$2.33K	Buy	29 +2	+7%	+$134	﹤0.01%	1297
2025 Q3	$1.32K	Hold	27	–	–	﹤0.01%	1477
2025 Q2	$2.02K	Hold	27	–	–	﹤0.01%	1364
2025 Q1	$1.72K	Sell	27 -7	-21%	-$476	﹤0.01%	1362
2024 Q4	$2.65K	Hold	34	–	–	﹤0.01%	1218
2024 Q3	$2.73K	Buy	34 +1	+3%	+$81	﹤0.01%	1228
2024 Q2	$2.73K	Buy	33 +6	+22%	+$528	﹤0.01%	1224
2024 Q1	$2.31K	Hold	27	–	–	﹤0.01%	1294
2023 Q4	$2.31K	Hold	27	–	–	﹤0.01%	1265
2023 Q3	$2.42K	Hold	27	–	–	﹤0.01%	1181
2023 Q2	$2.3K	Hold	27	–	–	﹤0.01%	1227
2023 Q1	$2.23K	Hold	27	–	–	﹤0.01%	1204
2022 Q4	$2.12K	Hold	27	–	–	﹤0.01%	1258
2022 Q3	$2K	Hold	27	–	–	﹤0.01%	1111
2022 Q2	$2K	Buy	+27	New	+$1.6K	﹤0.01%	1151
2021 Q4	$1K	Sell	10 -17	-63%	-$1.04K	﹤0.01%	1456
2021 Q3	$2K	Buy	+27	New	+$1.7K	﹤0.01%	1075

Other funds holding HAE

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Neuberger Berman Group New York $150B AUM 40.08% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return

Ariel Investments Chicago, Illinois $10B AUM 42.59% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

Citadel Advisors Miami, Florida $875B AUM 40.91% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Bell Investment Advisors's HAE Position: Q2 2026 in Review

Bell Investment Advisors held its Haemonetics (HAE) position steady in Q2 2026 at 29 shares worth $2.17K. The position accounts for ﹤0.01% of the portfolio, ranked #1309.

Bell Investment Advisors first reported a position in HAE in Q3 2021 and has held it in 19 quarters since. The position peaked at $2.73K in Q3 2024. 329 funds tracked by Wall St. Rank hold HAE as of Q2 2026.

Bell Investment Advisors held 29 shares of Haemonetics worth $2.17K as of Q2 2026.
Bell Investment Advisors left its Haemonetics share count unchanged in Q2 2026.
Haemonetics made up ﹤0.01% of Bell Investment Advisors's portfolio in Q2 2026, its #1309 holding.
Bell Investment Advisors first reported a position in Haemonetics in Q3 2021 and has held it in 19 quarters since.
Bell Investment Advisors's Haemonetics position peaked at $2.73K in Q3 2024.
329 funds tracked by Wall St. Rank held Haemonetics as of Q2 2026.

Based on Bell Investment Advisors's 13F filing for Q2 2026, filed 7 Aug 2026.